Stock Track | Encore Capital Soars 7.58% on Strong Q3 Results, Beating Earnings and Revenue Estimates

Stock Track11-06

Encore Capital Group (NASDAQ: ECPG) saw its stock price surge 7.58% in Thursday's trading session following the release of its impressive third-quarter 2025 financial results. The company significantly outperformed analyst expectations, demonstrating robust growth across its key markets.

The debt recovery solutions provider reported earnings per share of $3.17 for Q3, marking a substantial 152% increase from $1.26 in the same period last year. This figure handily beat the analyst consensus estimate of $1.83. Encore Capital's quarterly revenue also impressed, coming in at $460.353 million, up 25.41% year-over-year and surpassing the analyst estimate of $410.694 million by 12.09%. The company's net income for the quarter reached $74.66 million, significantly exceeding the expected $43.3 million.

Encore Capital's strong performance was driven by exceptional results in both its U.S. and European markets. In the U.S., the company's MCM business saw portfolio purchases increase by 13% to $261 million, while collections surged 25% to a record $502 million. The European Cabot business also delivered solid results, with higher-than-usual portfolio purchases of $85 million and collections growth of 8% to $160 million. In light of these positive outcomes, Encore Capital raised its full-year 2025 collections guidance to approximately $2.55 billion and announced a $300 million share repurchase program reauthorization, further boosting investor confidence.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment